Company Overview

Balaji Amines Limited (BSE: 530999, NSE: BALAMINES) convened its 38th Annual General Meeting on July 10, 2026, and published comprehensive FY26 financial results demonstrating strong operational performance and strategic expansion.

Financial Performance

FY26 Consolidated Results:

  • Revenue from Operations: ₹1,42,498.07 lakhs (₹1,454 crore)
  • Total Income: ₹1,45,378.74 lakhs
  • Profit Before Tax: ₹23,249.02 lakhs
  • Profit After Tax: ₹16,915.68 lakhs (₹169 crore), up 6% YoY

Standalone Performance:

  • Revenue: ₹1,29,154.47 lakhs (₹1,291.54 crore)
  • PAT: ₹16,552.83 lakhs (₹165.53 crore)
  • EPS: ₹51.09 per share
  • Q4 FY26 Performance: Revenue ₹403 crore, PAT ₹65 crore (up 62% YoY)

Dividend Declaration & Capital Structure

The Board recommended a final dividend of ₹11 per equity share (550% of face value ₹2) for the seventh consecutive year, involving cash outflow of ₹3,564.11 lakhs. The company maintained a debt-free standalone balance sheet with paid-up capital of ₹6,48,02,000.

Operational Highlights & Expansion

Production Metrics: Total production reached 1,06,970 MT across aliphatic amines (29,997 MT), speciality chemicals (42,334 MT), and derivatives (34,640 MT).

Completed Projects: MIPA plant commissioned at Unit I, Electronic Grade Dimethyl Carbonate plant, and 6 MW solar power plant.

Ongoing Expansion: ₹750 crore BSCL expansion granted Mega Project status, including:

  • Dimethyl Ether (DME) plant (1,00,000 TPA) commissioned Q1 FY27
  • N-Methyl Morpholine (NMM) plant (~5,000 TPA) commissioning in FY27
  • Acetonitrile expansion to 60 MT/day at Unit III
  • BSCL Unit I (EDA derivatives) commissioning September 2026
  • BSCL Unit II (HCN, NaCN, EDTA) commissioning Q4 FY27

Export Performance & Geographical Revenue

Exports contributed 14.30% of consolidated revenue, reaching 50+ countries with Europe accounting for 36.76% of export revenue. USA was the largest market at ₹4,573.78 lakhs, followed by Italy (₹3,484.27 lakhs) and Spain (₹1,719.75 lakhs).

Subsidiary Performance

Balaji Speciality Chemicals Limited (55% subsidiary) reported:

  • Turnover: ₹15,241.43 lakhs
  • Profit After Tax: ₹434.87 lakhs
  • Total Assets: ₹81,801.83 lakhs

The parent company contributed 97.85% to consolidated profit while subsidiaries accounted for 2.15%.

Accounting Policy Change

The company changed inventory costing method from FIFO to weighted average basis effective April 1, 2025, increasing profit before tax by ₹162.11 lakhs. Auditors issued unqualified opinion confirming clean financial statements and effective internal financial controls.

Corporate Governance & Compliance

Board Composition: 8 Directors (4 Executive, 4 Independent including 2 women directors) with 4 board meetings held during FY26.

Key Management: Mr. Ande Pratap Reddy (Executive Chairman), Mr. Dundurapu Ram Reddy (Managing Director), Mr. Ande Srinivas Reddy (Whole-time Director & CFO).

Regulatory Compliance: Confirmed compliance with all applicable laws including Companies Act 2013 and SEBI Listing Regulations. No material regulatory actions or penalties reported.

ESG Initiatives & Workforce

Environmental: Zero Liquid Discharge implementation, 6 MW solar plant generating ~30% energy, water recycling measures.

Social: Total workforce of 1,161 employees, CSR expenditure of ₹3.24 crore benefiting 27,24,372 people through 104 community programs.

Governance: Whistle Blower Policy implementation, Anti-Sexual Harassment Policy with no complaints received during FY26.

Forward Guidance

Management guided for 10-15% consolidated volume growth in FY27 with EBITDA margins in 22-23% range. Medium-term expectation of 20-30% volume growth as new projects contribute progressively.